Annual Drug Patent Expirations for VOQUEZNA+DUAL+PAK Voquezna Dual Pak is a drug marketed by Phathom and is included in one NDA. The generic ingredient in VOQUEZNA DUAL PAK is amoxicillin;…
The post New patent for Phathom drug VOQUEZNA DUAL PAK appeare…
Annual Drug Patent Expirations for VOQUEZNA+TRIPLE+PAK Voquezna Triple Pak is a drug marketed by Phathom and is included in one NDA. The generic ingredient in VOQUEZNA TRIPLE PAK is amoxicillin;…
The post New patent for Phathom drug VOQUEZNA TRIPLE PAK…
This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug patent…
Which pharmaceutical companies have the most drug patents in Spain? Read Post »
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from two suppliers.…
The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPaten…
Annual Drug Patent Expirations for RYBELSUS Rybelsus is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for NOVO drug RYBELSUS appeared first on DrugPatentWa…
Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…
Pharmaceutical companies with the most orphan drugs Read Post »
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are fourteen…
The post New patent expiration for Acadia Pharms drug NUPLAZID appeared fir…
New patent expiration for Acadia Pharms drug NUPLAZID Read Post »
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are thirty-five patents protecting this drug. This drug…
The post New patent for Amicus Therap drug GALAFOLD appeared first on…
This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2017 to 2022. Companies that successfully challenge patents on branded drugs are granted six…
The post Most prolific drug patent challengers …
Annual Drug Patent Expirations for CAROSPIR Carospir is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from two suppliers. There are five…
The post New patent for Cmp Dev drug CAROSPIR appeared first on DrugPatentWatch – Mak…
Get new actionable insights and updates from BiotechBlog
